News

Ms Sainz succeeds Gary Curtis, who served as the CEO of the company since July 2002 and who recently decided to step down. Most recently Ms Sainz was

Triphendiol also potently sensitizes pancreatic and bile duct cancer cell lines and xenograft tumors to the standard of care drug, gemcitabine. This study assessed the potential of triphendiol

These new solutions allow researchers to leverage synergies across Illumina technology platforms to better understand the complex molecular mechanisms that give rise to cancer. DASL Assay was specifically

The data were generated from a Phase III study that prospectively evaluated patients with biomarkers identified from earlier clinical studies. These results confirm the predictive value of p53

In vitro and in vivo studies of U3-1287 (AMG 888), which is being developed in partnership with Amgen, demonstrate that the antibody inhibits oncogenic signaling and proliferation of

The patent relates to Fosamax once weekly (alendronate 70mg once weekly). This favorable decision follows a similar judgment rendered by the Hague District Court in the Netherlands regarding

The trial investigated both prevention (n=288) and treatment (n=545) of Glucocorticoid-induced osteoporosis (GIO) in patients. Results demonstrated that a single yearly infusion of Reclast significantly increased bone mineral

As a result of the transaction, CollaGenex has become a wholly owned subsidiary of Galderma Laboratories. Upon closing of the acquisition, all remaining outstanding shares of CollaGenex common

To be eligible to participate in this study, a patient must have been diagnosed with prostate cancer that has recurred after completing treatment by external beam radiation therapy